A Delphi Deprescribing Study Ranked Strategies Rather Than Testing Cessation

Written by

in

Agreement about priorities is not evidence that an intervention works.

What the paper found

The study used a multi-round Delphi process to identify and prioritize ways to support general practitioners in benzodiazepine-receptor-agonist deprescribing. Recommendations included approaches responsive to clinician and patient needs, with differing views about digital tools.

Limits of the evidence

The process was designed to build consensus, not randomize patients to competing strategies. Panel composition, attrition and the planned stopping point can influence rankings. A favored tool has not thereby demonstrated clinical effectiveness.

Implications for case review

Use the paper as implementation-planning evidence. It cannot establish a discontinuation rate, optimal taper or individual outcome. Distinguish professional preference, service feasibility and measured patient benefit when evaluating claims that a specific support method is proven.

Source and related reading

Source: PMC12964182, supplied full-text paper. Findings are paraphrased; forensic implications are an interpretation.

Related: A Benzodiazepine-Positive Result After Emergency Sedation May Reflect Treatment Rather Than the Initial Overdose.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *